EDITORIAL POLICY
How Rethiamine.com handles evidence
Rethiamine.com is the flagship record of a proprietary formulation programme. That position demands stricter editorial discipline, not looser: these are the rules every page follows.
Evidence selection
This site prefers primary literature, trial registries, regulator pages, universities, manufacturers’ official research announcements and major scientific institutions. News journalism is excluded from the evidence base. Every reference is verified against the original source before publication; bibliographic data (citations, PMIDs, DOIs, URLs) was last verified on 2026-08-01.
Use of primary sources
Every scientific claim links outward to the original source — PubMed records, journal pages, ClinicalTrials.gov entries or official sponsor announcements — and is accompanied by a statement of what the source supports and what it does not show. Company topline announcements are labelled as such and are never presented as peer-reviewed results.
Established findings versus Panacea hypotheses
The site maintains an explicit boundary between what published research establishes and what Panacea Bio Chem is investigating. Hypotheses are labelled as hypotheses; the evidence-versus-hypothesis page is the canonical statement of that boundary; no Panacea experimental results are claimed before they exist.
Balanced reporting
Unfavourable and neutral findings are displayed at the same prominence as favourable ones. Where retatrutide cardiovascular outcomes are mentioned, TRIUMPH-3’s neutral MACE-3 hazard ratio of 1.12 (95% CI 0.64-1.96) is reported alongside the weight-loss readouts.
Conflict-of-interest disclosure
Rethiamine™ is a proprietary Panacea Bio Chem formulation, and this site is published by Panacea Bio Chem Scientific Communications — that interest is declared on every page. Where cited external studies carry declared conflicts (for example, sponsor-run trials), the limitation is stated beside the citation.
Investigational status
Every page carries the scientific-status line: research formulation under development. The full regulatory and scientific notice lives on the research-status page, and a concise version appears in every footer.
Corrections
Dates on this site are real: the “last evidence search” date changes only when the references have genuinely been rechecked. Factual errors, when identified, are corrected in the content and reflected in the page modification date.